http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2018219977-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2018-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e61ae802e5e7a41c68307b713027da4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a962831d34e0c3455ac9a5023c3c9cfc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af16f995458e244f07bfb7c91c40306f |
| publicationDate | 2018-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2018219977-A1 |
| titleOfInvention | K-ras mutations and anti-EGFr antibody therapy field |
| abstract | The present application relates to K-ras mutations, to polynucleotides encoding mutant K-ras polypeptides, and to methods of identifying K-ras mutations. The present application also relates to methods of diagnosing cancer; and methods and kits for predicting usefulness of anti-EGFr specific binding agents in the treatment of tumors. |
| priorityDate | 2007-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 384.